Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do noradrenergic reuptake inhibitors affect serotonergic function in depression?

A J Cleare1, R M Murray, V O'Keane

  • 1Department of Psychological Medicine, Institute of Psychiatry, London, UK.

Psychopharmacology
|February 6, 1998
PubMed
Summary

d-Fenfluramine challenges revealed antidepressant effects on serotonin (5-HT) function in major depression. Treatment altered prolactin and cortisol responses, indicating neuroendocrine changes independent of clinical improvement.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating behavioral inertia in passively sensed smartphone parameters to differentiate affective episodes in patients with bipolar disorder.

Neuroscience applied·2026
Same author

Shared decision-making in depression: From a generalized ethical imperative to a personalized approach? A narrative review.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

Multiple-therapy-resistant major depressive disorder: a clinically important concept.

The British journal of psychiatry : the journal of mental science·2018
Same author

Hair cortisol and childhood trauma predict psychological therapy response in depression and anxiety disorders.

Acta psychiatrica Scandinavica·2018
Same author

A morphometric signature of depressive symptoms in unmedicated patients with mood disorders.

Acta psychiatrica Scandinavica·2018
Same author

Short-term and long-term measures of cortisol in saliva and hair in atypical and non-atypical depression.

Acta psychiatrica Scandinavica·2018

Area of Science:

  • Neuroendocrinology
  • Psychopharmacology
  • Major Depressive Disorder

Background:

  • Major depressive disorder (MDD) is often associated with altered serotonergic (5-HT) neurotransmission.
  • Serotonergic neuroendocrine challenges are used to assess 5-HT system function in MDD.

Purpose of the Study:

  • To investigate the effects of antidepressant treatment on serotonergic function in patients with unipolar major depression.
  • To assess neuroendocrine responses to d-fenfluramine before and after treatment with a noradrenergic reuptake inhibitor, tricyclic antidepressant, or placebo.

Main Methods:

  • A serotonergic neuroendocrine challenge using d-fenfluramine (30 mg) was administered to patients with MDD at baseline.
  • Patients received 6 weeks of treatment with a noradrenergic reuptake inhibitor, tricyclic antidepressant, or placebo.

Related Experiment Videos

  • Prolactin and cortisol responses to d-fenfluramine were measured post-treatment.

    • Main Results:

    • Antidepressant treatment increased prolactin responses to d-fenfluramine, irrespective of treatment outcome.
    • Patients treated with a noradrenergic reuptake inhibitor showed enhanced 5-HT-mediated cortisol responses post-treatment, independent of depression improvement.

    Conclusions:

    • Antidepressants that modulate noradrenergic function also impact the serotonin system, as evidenced by neuroendocrine changes.
    • These findings suggest complex interactions between noradrenergic and serotonergic systems in the pathophysiology and treatment of depression.